Perrigo Company plc Stock TEL AVIV STOCK EXCHANGE
Stocks
PRGO
IE00BGH1M568
Pharmaceuticals
| Market Cap | 1.98B 5.92B 1.7B 1.59B 1.45B 2.74B 189B 2.77B 18.77B 7.3B 95.02B 7.42B 7.26B 315B | P/E 2026 * |
1,427x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4.88B 14.61B 4.19B 3.92B 3.58B 6.76B 467B 6.83B 46.34B 18.01B 235B 18.33B 17.93B 777B | EV / Sales 2026 * |
1.2x | EV / Sales 2027 * | 1.16x |
| Free-Float |
99.6% | Yield 2026 * |
8.11% | Yield 2027 * | 8.32% |
Last Transcript: Perrigo Company plc
| 1 day | +0.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Manzone
CEO | Chief Executive Officer | 63 | 2026-06-06 |
Eduardo Bezerra
DFI | Director of Finance/CFO | 51 | 2022-05-15 |
Matt Winterman
COO | Chief Operating Officer | - | 2025-06-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Donal O'Connor
BRD | Director/Board Member | 75 | 2014-10-31 |
Geoffrey Parker
BRD | Director/Board Member | 61 | 2016-11-06 |
Bradley Alford
BRD | Director/Board Member | 70 | 2017-02-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | -2.55% | - | - | 1.98B | |
| -0.67% | +5.66% | +75.21% | +125.34% | 1,119B | |
| +1.04% | +4.87% | +52.29% | +65.95% | 651B | |
| -0.17% | +6.04% | +25.60% | +79.85% | 468B | |
| -1.38% | +4.31% | +41.64% | +41.08% | 374B | |
| -0.52% | +3.53% | +24.32% | +40.27% | 302B | |
| -1.06% | +5.67% | +1.19% | +12.44% | 259B | |
| +1.03% | +6.90% | +51.11% | +72.46% | 238B | |
| -0.53% | +1.54% | -17.77% | -54.10% | 208B | |
| +0.42% | +6.06% | +27.86% | +90.47% | 181B | |
| Average | -0.14% | +5.17% | +31.27% | +52.64% | 422.21B | |
| Weighted average by Cap. | -0.08% | +5.40% | +43.93% | +72.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.06B 12.15B 3.48B 3.26B 2.98B 5.62B 389B 5.68B 38.53B 14.98B 195B 15.24B 14.91B 646B | 4.09B 12.24B 3.51B 3.28B 3B 5.66B 391B 5.72B 38.82B 15.09B 196B 15.35B 15.02B 650B |
| Net income | -224M -671M -192M -180M -164M -310M -21.45B -313M -2.13B -827M -10.77B -841M -823M -35.64B | -56.95M -170M -48.82M -45.69M -41.77M -78.83M -5.45B -79.66M -541M -210M -2.74B -214M -209M -9.06B |
| Net Debt | 2.9B 8.69B 2.49B 2.33B 2.13B 4.02B 278B 4.06B 27.57B 10.72B 140B 10.91B 10.67B 462B | 2.78B 8.33B 2.39B 2.23B 2.04B 3.85B 267B 3.89B 26.42B 10.27B 134B 10.45B 10.22B 443B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
